Research Paper Volume 16, Issue 15 pp 11553—11567
The deubiquitinating enzymes-related signature predicts the prognosis and immunotherapy response in breast cancer
Figure 5. Molecular docking pose. Utilizing molecular docking to screen potential small compounds for target proteins. Figure shows the OTUB2 active pocket with Trypargine (A), Ormosanine (B), Urothion (C), Piptanthine (D), Sagittatin A (E), Tetrahydropentoxyline (F), Scroside B (G) and Thalirugidine (H) in docking position.